Cannenta

Cannenta is a biotechnology company based in Hawthorn, Victoria, dedicated to providing affordable and effective advanced wound care products for emerging markets globally. Their innovative technology, which utilizes a patented sugar-based angiogenesis factor, aims to accelerate wound recovery, particularly for patients suffering from diabetic foot ulcers and other challenging wounds.

The company is currently involved in clinical trials in Australia, focusing on their lead hydrogel-based product and plans to expand its product range to address various chronic and difficult-to-heal wounds. With a team of experienced professionals in healthcare and biotechnology, Cannenta is well-positioned to enhance wound healing through their cutting-edge solutions.

Generated from the website